According to the research report, the global market for AI In Vitro Diagnostic should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The global market for in vitro diagnostics (IVD) was growing steadily and was expected to continue its growth in the coming years.
Market Overview: The in vitro diagnostics market involves medical devices, instruments, and reagents used for diagnostic testing of samples such as blood, urine, tissue, and other bodily fluids. AI in vitro diagnostics refers to the integration of artificial intelligence and machine learning technologies into these diagnostic tools and processes.
Growth Drivers: The market for AI in vitro diagnostics has been driven by factors such as increasing demand for personalized medicine, rising prevalence of chronic and infectious diseases, technological advancements in diagnostics, and the need for efficient and accurate diagnostic solutions.
Application Areas: AI has found applications in various areas of in vitro diagnostics, including clinical chemistry, immunoassays, microbiology, hematology, genetic testing, and molecular diagnostics. AI algorithms can aid in data analysis, interpretation, and decision-making, improving the accuracy and efficiency of diagnostic procedures.
This report aims to provide a comprehensive study of the global market for AI In Vitro Diagnostic. Key Takeaways and Highlights
(1) Global AI In Vitro Diagnostic market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global AI In Vitro Diagnostic market competitive situation, revenue and market share, from 2018 to 2022.
(3) China AI In Vitro Diagnostic market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global AI In Vitro Diagnostic segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global AI In Vitro Diagnostic segment by type and by application and regional segment by type and by application.
(6) AI In Vitro Diagnostic industry supply chain, upstream, midstream and downstream analysis.
Regional Breakdown: Analyzing Market Segments by Geography
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Segmenting by Type: Comprehensive Coverage and Analysis
Next-Generation Sequencing Technology
PCR Technology
Chemistry and IA Technology
Pathology Technology
Application-Based Segmentation: Unlocking Market Opportunities
Cancer Diagnostics
Infectious Disease Testing
Metabolic Testing
Cardiac Testing
Diabetes Testing
In the Spotlight: A Closer Look at Market Players
Renalytix
Seegene
Sysmex
PathAI
Prognos
Qiagen
CloudMedX Health
Deepcell
Digital Diagnostics
EKF Diagnostics Holdings
Freenome
GE Healthcare
Glooko
Adaptive Biotechnologies
Aidoc
Anumana
ARUP Laboratories
K Health
Lunit
1 Market Overview
1.1 Product Overview and Scope of AI In Vitro Diagnostic
1.2 Global AI In Vitro Diagnostic Market Size and Forecast
1.3 China AI In Vitro Diagnostic Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China AI In Vitro Diagnostic Share in Global Market, 2018-2029
1.4.2 AI In Vitro Diagnostic Market Size: China VS Global, 2018-2029
1.5 AI In Vitro Diagnostic Market Dynamics
1.5.1 AI In Vitro Diagnostic Market Drivers
1.5.2 AI In Vitro Diagnostic Market Restraints
1.5.3 AI In Vitro Diagnostic Industry Trends
1.5.4 AI In Vitro Diagnostic Industry Policy
2 Global Competitive Situation by Company
2.1 Global AI In Vitro Diagnostic Revenue by Company (2018-2023)
2.2 Global AI In Vitro Diagnostic Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global AI In Vitro Diagnostic Concentration Ratio
2.4 Global AI In Vitro Diagnostic Mergers & Acquisitions, Expansion Plans
2.5 Global AI In Vitro Diagnostic Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China AI In Vitro Diagnostic Revenue by Company (2018-2023)
3.2 China AI In Vitro Diagnostic AI In Vitro Diagnostic Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China AI In Vitro Diagnostic, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 AI In Vitro Diagnostic Industry Chain
4.2 AI In Vitro Diagnostic Upstream Analysis
4.3 AI In Vitro Diagnostic Midstream Analysis
4.4 AI In Vitro Diagnostic Downstream Analysis
5 Sights by Type
5.1 AI In Vitro Diagnostic Classification
5.1.1 Next-Generation Sequencing Technology
5.1.2 PCR Technology
5.1.3 Chemistry and IA Technology
5.1.4 Pathology Technology
5.2 By Type, Global AI In Vitro Diagnostic Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global AI In Vitro Diagnostic Revenue, 2018-2029
6 Sights by Application
6.1 AI In Vitro Diagnostic Segment by Application
6.1.1 Cancer Diagnostics
6.1.2 Infectious Disease Testing
6.1.3 Metabolic Testing
6.1.4 Cardiac Testing
6.1.5 Diabetes Testing
6.2 By Application, Global AI In Vitro Diagnostic Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global AI In Vitro Diagnostic Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global AI In Vitro Diagnostic Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global AI In Vitro Diagnostic Market Size, 2018-2029
7.3 North America
7.3.1 North America AI In Vitro Diagnostic Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America AI In Vitro Diagnostic Market Size Market Share
7.4 Europe
7.4.1 Europe AI In Vitro Diagnostic Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe AI In Vitro Diagnostic Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific AI In Vitro Diagnostic Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific AI In Vitro Diagnostic Market Size Market Share
7.6 South America
7.6.1 South America AI In Vitro Diagnostic Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America AI In Vitro Diagnostic Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global AI In Vitro Diagnostic Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global AI In Vitro Diagnostic Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. AI In Vitro Diagnostic Market Size, 2018-2029
8.3.2 By Company, U.S. AI In Vitro Diagnostic Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe AI In Vitro Diagnostic Market Size, 2018-2029
8.4.2 By Company, Europe AI In Vitro Diagnostic Revenue Market Share, 2018-2023
8.4.3 By Type, Europe AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China AI In Vitro Diagnostic Market Size, 2018-2029
8.5.2 By Company, China AI In Vitro Diagnostic Revenue Market Share, 2018-2023
8.5.3 By Type, China AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan AI In Vitro Diagnostic Market Size, 2018-2029
8.6.2 By Company, Japan AI In Vitro Diagnostic Revenue Market Share, 2018-2023
8.6.3 By Type, Japan AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea AI In Vitro Diagnostic Market Size, 2018-2029
8.7.2 By Company, South Korea AI In Vitro Diagnostic Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia AI In Vitro Diagnostic Market Size, 2018-2029
8.8.2 By Company, Southeast Asia AI In Vitro Diagnostic Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India AI In Vitro Diagnostic Market Size, 2018-2029
8.9.2 By Company, India AI In Vitro Diagnostic Revenue Market Share, 2018-2023
8.9.3 By Type, India AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia AI In Vitro Diagnostic Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia AI In Vitro Diagnostic Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Renalytix
9.1.1 Renalytix Company Information, Head Office, Market Area and Industry Position
9.1.2 Renalytix Company Profile and Main Business
9.1.3 Renalytix AI In Vitro Diagnostic Models, Specifications and Application
9.1.4 Renalytix AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.1.5 Renalytix Recent Developments
9.2 Seegene
9.2.1 Seegene Company Information, Head Office, Market Area and Industry Position
9.2.2 Seegene Company Profile and Main Business
9.2.3 Seegene AI In Vitro Diagnostic Models, Specifications and Application
9.2.4 Seegene AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.2.5 Seegene Recent Developments
9.3 Sysmex
9.3.1 Sysmex Company Information, Head Office, Market Area and Industry Position
9.3.2 Sysmex Company Profile and Main Business
9.3.3 Sysmex AI In Vitro Diagnostic Models, Specifications and Application
9.3.4 Sysmex AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.3.5 Sysmex Recent Developments
9.4 PathAI
9.4.1 PathAI Company Information, Head Office, Market Area and Industry Position
9.4.2 PathAI Company Profile and Main Business
9.4.3 PathAI AI In Vitro Diagnostic Models, Specifications and Application
9.4.4 PathAI AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.4.5 PathAI Recent Developments
9.5 Prognos
9.5.1 Prognos Company Information, Head Office, Market Area and Industry Position
9.5.2 Prognos Company Profile and Main Business
9.5.3 Prognos AI In Vitro Diagnostic Models, Specifications and Application
9.5.4 Prognos AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.5.5 Prognos Recent Developments
9.6 Qiagen
9.6.1 Qiagen Company Information, Head Office, Market Area and Industry Position
9.6.2 Qiagen Company Profile and Main Business
9.6.3 Qiagen AI In Vitro Diagnostic Models, Specifications and Application
9.6.4 Qiagen AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.6.5 Qiagen Recent Developments
9.7 CloudMedX Health
9.7.1 CloudMedX Health Company Information, Head Office, Market Area and Industry Position
9.7.2 CloudMedX Health Company Profile and Main Business
9.7.3 CloudMedX Health AI In Vitro Diagnostic Models, Specifications and Application
9.7.4 CloudMedX Health AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.7.5 CloudMedX Health Recent Developments
9.8 Deepcell
9.8.1 Deepcell Company Information, Head Office, Market Area and Industry Position
9.8.2 Deepcell Company Profile and Main Business
9.8.3 Deepcell AI In Vitro Diagnostic Models, Specifications and Application
9.8.4 Deepcell AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.8.5 Deepcell Recent Developments
9.9 Digital Diagnostics
9.9.1 Digital Diagnostics Company Information, Head Office, Market Area and Industry Position
9.9.2 Digital Diagnostics Company Profile and Main Business
9.9.3 Digital Diagnostics AI In Vitro Diagnostic Models, Specifications and Application
9.9.4 Digital Diagnostics AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.9.5 Digital Diagnostics Recent Developments
9.10 EKF Diagnostics Holdings
9.10.1 EKF Diagnostics Holdings Company Information, Head Office, Market Area and Industry Position
9.10.2 EKF Diagnostics Holdings Company Profile and Main Business
9.10.3 EKF Diagnostics Holdings AI In Vitro Diagnostic Models, Specifications and Application
9.10.4 EKF Diagnostics Holdings AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.10.5 EKF Diagnostics Holdings Recent Developments
9.11 Freenome
9.11.1 Freenome Company Information, Head Office, Market Area and Industry Position
9.11.2 Freenome Company Profile and Main Business
9.11.3 Freenome AI In Vitro Diagnostic Models, Specifications and Application
9.11.4 Freenome AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.11.5 Freenome Recent Developments
9.12 GE Healthcare
9.12.1 GE Healthcare Company Information, Head Office, Market Area and Industry Position
9.12.2 GE Healthcare Company Profile and Main Business
9.12.3 GE Healthcare AI In Vitro Diagnostic Models, Specifications and Application
9.12.4 GE Healthcare AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.12.5 GE Healthcare Recent Developments
9.13 Glooko
9.13.1 Glooko Company Information, Head Office, Market Area and Industry Position
9.13.2 Glooko Company Profile and Main Business
9.13.3 Glooko AI In Vitro Diagnostic Models, Specifications and Application
9.13.4 Glooko AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.13.5 Glooko Recent Developments
9.14 Adaptive Biotechnologies
9.14.1 Adaptive Biotechnologies Company Information, Head Office, Market Area and Industry Position
9.14.2 Adaptive Biotechnologies Company Profile and Main Business
9.14.3 Adaptive Biotechnologies AI In Vitro Diagnostic Models, Specifications and Application
9.14.4 Adaptive Biotechnologies AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.14.5 Adaptive Biotechnologies Recent Developments
9.15 Aidoc
9.15.1 Aidoc Company Information, Head Office, Market Area and Industry Position
9.15.2 Aidoc Company Profile and Main Business
9.15.3 Aidoc AI In Vitro Diagnostic Models, Specifications and Application
9.15.4 Aidoc AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.15.5 Aidoc Recent Developments
9.16 Anumana
9.16.1 Anumana Company Information, Head Office, Market Area and Industry Position
9.16.2 Anumana Company Profile and Main Business
9.16.3 Anumana AI In Vitro Diagnostic Models, Specifications and Application
9.16.4 Anumana AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.16.5 Anumana Recent Developments
9.17 ARUP Laboratories
9.17.1 ARUP Laboratories Company Information, Head Office, Market Area and Industry Position
9.17.2 ARUP Laboratories Company Profile and Main Business
9.17.3 ARUP Laboratories AI In Vitro Diagnostic Models, Specifications and Application
9.17.4 ARUP Laboratories AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.17.5 ARUP Laboratories Recent Developments
9.18 K Health
9.18.1 K Health Company Information, Head Office, Market Area and Industry Position
9.18.2 K Health Company Profile and Main Business
9.18.3 K Health AI In Vitro Diagnostic Models, Specifications and Application
9.18.4 K Health AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.18.5 K Health Recent Developments
9.19 Lunit
9.19.1 Lunit Company Information, Head Office, Market Area and Industry Position
9.19.2 Lunit Company Profile and Main Business
9.19.3 Lunit AI In Vitro Diagnostic Models, Specifications and Application
9.19.4 Lunit AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
9.19.5 Lunit Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. AI In Vitro Diagnostic Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. AI In Vitro Diagnostic Market Restraints
Table 3. AI In Vitro Diagnostic Market Trends
Table 4. AI In Vitro Diagnostic Industry Policy
Table 5. Global AI In Vitro Diagnostic Revenue by Company (2018-2023) & (US$ million)
Table 6. Global AI In Vitro Diagnostic Revenue Market Share by Company (2018-2023)
Table 7. Global AI In Vitro Diagnostic Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global AI In Vitro Diagnostic Mergers & Acquisitions, Expansion Plans
Table 9. Global AI In Vitro Diagnostic Manufacturers Product Type
Table 10. China AI In Vitro Diagnostic Revenue by Company (2018-2023) & (US$ million)
Table 11. China AI In Vitro Diagnostic Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of AI In Vitro Diagnostic Upstream (Raw Materials)
Table 13. Global AI In Vitro Diagnostic Typical Customers
Table 14. AI In Vitro Diagnostic Typical Distributors
Table 15. By Type, Global AI In Vitro Diagnostic Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global AI In Vitro Diagnostic Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global AI In Vitro Diagnostic Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global AI In Vitro Diagnostic Revenue, 2018-2029, US$ Million
Table 19. By Country, Global AI In Vitro Diagnostic Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global AI In Vitro Diagnostic Revenue, 2018-2029, US$ Million
Table 21. By Country, Global AI In Vitro Diagnostic Revenue Market Share, 2018-2029
Table 22. Renalytix Company Information, Head Office, Market Area and Industry Position
Table 23. Renalytix Company Profile and Main Business
Table 24. Renalytix AI In Vitro Diagnostic Models, Specifications and Application
Table 25. Renalytix AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 26. Renalytix Recent Developments
Table 27. Seegene Company Information, Head Office, Market Area and Industry Position
Table 28. Seegene Company Profile and Main Business
Table 29. Seegene AI In Vitro Diagnostic Models, Specifications and Application
Table 30. Seegene AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 31. Seegene Recent Developments
Table 32. Sysmex Company Information, Head Office, Market Area and Industry Position
Table 33. Sysmex Company Profile and Main Business
Table 34. Sysmex AI In Vitro Diagnostic Models, Specifications and Application
Table 35. Sysmex AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 36. Sysmex Recent Developments
Table 37. PathAI Company Information, Head Office, Market Area and Industry Position
Table 38. PathAI Company Profile and Main Business
Table 39. PathAI AI In Vitro Diagnostic Models, Specifications and Application
Table 40. PathAI AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 41. PathAI Recent Developments
Table 42. Prognos Company Information, Head Office, Market Area and Industry Position
Table 43. Prognos Company Profile and Main Business
Table 44. Prognos AI In Vitro Diagnostic Models, Specifications and Application
Table 45. Prognos AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 46. Prognos Recent Developments
Table 47. Qiagen Company Information, Head Office, Market Area and Industry Position
Table 48. Qiagen Company Profile and Main Business
Table 49. Qiagen AI In Vitro Diagnostic Models, Specifications and Application
Table 50. Qiagen AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 51. Qiagen Recent Developments
Table 52. CloudMedX Health Company Information, Head Office, Market Area and Industry Position
Table 53. CloudMedX Health Company Profile and Main Business
Table 54. CloudMedX Health AI In Vitro Diagnostic Models, Specifications and Application
Table 55. CloudMedX Health AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 56. CloudMedX Health Recent Developments
Table 57. Deepcell Company Information, Head Office, Market Area and Industry Position
Table 58. Deepcell Company Profile and Main Business
Table 59. Deepcell AI In Vitro Diagnostic Models, Specifications and Application
Table 60. Deepcell AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 61. Deepcell Recent Developments
Table 62. Digital Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 63. Digital Diagnostics Company Profile and Main Business
Table 64. Digital Diagnostics AI In Vitro Diagnostic Models, Specifications and Application
Table 65. Digital Diagnostics AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 66. Digital Diagnostics Recent Developments
Table 67. EKF Diagnostics Holdings Company Information, Head Office, Market Area and Industry Position
Table 68. EKF Diagnostics Holdings Company Profile and Main Business
Table 69. EKF Diagnostics Holdings AI In Vitro Diagnostic Models, Specifications and Application
Table 70. EKF Diagnostics Holdings AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 71. EKF Diagnostics Holdings Recent Developments
Table 72. Freenome Company Information, Head Office, Market Area and Industry Position
Table 73. Freenome Company Profile and Main Business
Table 74. Freenome AI In Vitro Diagnostic Models, Specifications and Application
Table 75. Freenome AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 76. Freenome Recent Developments
Table 77. GE Healthcare Company Information, Head Office, Market Area and Industry Position
Table 78. GE Healthcare Company Profile and Main Business
Table 79. GE Healthcare AI In Vitro Diagnostic Models, Specifications and Application
Table 80. GE Healthcare AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 81. GE Healthcare Recent Developments
Table 82. Glooko Company Information, Head Office, Market Area and Industry Position
Table 83. Glooko Company Profile and Main Business
Table 84. Glooko AI In Vitro Diagnostic Models, Specifications and Application
Table 85. Glooko AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 86. Glooko Recent Developments
Table 87. Adaptive Biotechnologies Company Information, Head Office, Market Area and Industry Position
Table 88. Adaptive Biotechnologies Company Profile and Main Business
Table 89. Adaptive Biotechnologies AI In Vitro Diagnostic Models, Specifications and Application
Table 90. Adaptive Biotechnologies AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 91. Adaptive Biotechnologies Recent Developments
Table 92. Aidoc Company Information, Head Office, Market Area and Industry Position
Table 93. Aidoc Company Profile and Main Business
Table 94. Aidoc AI In Vitro Diagnostic Models, Specifications and Application
Table 95. Aidoc AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 96. Aidoc Recent Developments
Table 97. Anumana Company Information, Head Office, Market Area and Industry Position
Table 98. Anumana Company Profile and Main Business
Table 99. Anumana AI In Vitro Diagnostic Models, Specifications and Application
Table 100. Anumana AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 101. Anumana Recent Developments
Table 102. ARUP Laboratories Company Information, Head Office, Market Area and Industry Position
Table 103. ARUP Laboratories Company Profile and Main Business
Table 104. ARUP Laboratories AI In Vitro Diagnostic Models, Specifications and Application
Table 105. ARUP Laboratories AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 106. ARUP Laboratories Recent Developments
Table 107. K Health Company Information, Head Office, Market Area and Industry Position
Table 108. K Health Company Profile and Main Business
Table 109. K Health AI In Vitro Diagnostic Models, Specifications and Application
Table 110. K Health AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 111. K Health Recent Developments
Table 112. Lunit Company Information, Head Office, Market Area and Industry Position
Table 113. Lunit Company Profile and Main Business
Table 114. Lunit AI In Vitro Diagnostic Models, Specifications and Application
Table 115. Lunit AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023
Table 116. Lunit Recent Developments
List of Figure
Figure 1. AI In Vitro Diagnostic Picture
Figure 2. Global AI In Vitro Diagnostic Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China AI In Vitro Diagnostic Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China AI In Vitro Diagnostic Market Share of Global
Figure 5. Global AI In Vitro Diagnostic Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global AI In Vitro Diagnostic Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China AI In Vitro Diagnostic Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China AI In Vitro Diagnostic Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. AI In Vitro Diagnostic Industry Chain
Figure 10. Next-Generation Sequencing Technology
Figure 11. PCR Technology
Figure 12. Chemistry and IA Technology
Figure 13. Pathology Technology
Figure 14. By Type, Global AI In Vitro Diagnostic Revenue, 2018-2029, US$ Million
Figure 15. By Type, Global AI In Vitro Diagnostic Revenue Market Share, 2018-2029
Figure 16. Cancer Diagnostics
Figure 17. Infectious Disease Testing
Figure 18. Metabolic Testing
Figure 19. Cardiac Testing
Figure 20. Diabetes Testing
Figure 21. By Application, Global AI In Vitro Diagnostic Revenue, 2018-2029, US$ Million
Figure 22. By Application, Global AI In Vitro Diagnostic Revenue Market Share, 2018-2029
Figure 23. By Region, Global AI In Vitro Diagnostic Revenue Market Share, 2018-2029
Figure 24. North America AI In Vitro Diagnostic Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, North America AI In Vitro Diagnostic Revenue Market Share, 2018-2023
Figure 26. Europe AI In Vitro Diagnostic Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, Europe AI In Vitro Diagnostic Revenue Market Share, 2018-2023
Figure 28. Asia Pacific AI In Vitro Diagnostic Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. By Country/Region, Asia Pacific AI In Vitro Diagnostic Revenue Market Share, 2018-2023
Figure 30. South America AI In Vitro Diagnostic Revenue & Forecasts, 2018-2029, US$ Million
Figure 31. By Country, South America AI In Vitro Diagnostic Revenue Market Share, 2018-2023
Figure 32. Middle East & Africa AI In Vitro Diagnostic Revenue & Forecasts, 2018-2029, US$ Million
Figure 33. U.S. AI In Vitro Diagnostic Revenue, 2018-2029, (US$ Million)
Figure 34. By Company, U.S. AI In Vitro Diagnostic Market Share, 2018-2023
Figure 35. By Type, U.S. AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 36. By Application, U.S. AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 37. Europe AI In Vitro Diagnostic Revenue, 2018-2029, (US$ Million)
Figure 38. By Company, Europe AI In Vitro Diagnostic Market Share, 2018-2023
Figure 39. By Type, Europe AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 40. By Application, Europe AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 41. China AI In Vitro Diagnostic Revenue, 2018-2029, (US$ Million)
Figure 42. By Company, China AI In Vitro Diagnostic Market Share, 2018-2023
Figure 43. By Type, China AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 44. By Application, China AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 45. Japan AI In Vitro Diagnostic Revenue, 2018-2029, (US$ Million)
Figure 46. By Company, Japan AI In Vitro Diagnostic Market Share, 2018-2023
Figure 47. By Type, Japan AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 48. By Application, Japan AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 49. South Korea AI In Vitro Diagnostic Revenue, 2018-2029, (US$ Million)
Figure 50. By Company, South Korea AI In Vitro Diagnostic Market Share, 2018-2023
Figure 51. By Type, South Korea AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 52. By Application, South Korea AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 53. Southeast Asia AI In Vitro Diagnostic Revenue, 2018-2029, (US$ Million)
Figure 54. By Company, Southeast Asia AI In Vitro Diagnostic Market Share, 2018-2023
Figure 55. By Type, Southeast Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 56. By Application, Southeast Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 57. India AI In Vitro Diagnostic Revenue, 2018-2029, (US$ Million)
Figure 58. By Company, India AI In Vitro Diagnostic Market Share, 2018-2023
Figure 59. By Type, India AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 60. By Application, India AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 61. Middle East & Asia AI In Vitro Diagnostic Revenue, 2018-2029, (US$ Million)
Figure 62. By Company, Middle East & Asia AI In Vitro Diagnostic Market Share, 2018-2023
Figure 63. By Type, Middle East & Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 64. By Application, Middle East & Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029
Figure 65. Research Methodology
Figure 66. Breakdown of Primary Interviews
Figure 67. Bottom-up Approaches
Figure 68. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|